Sort
82,697 grants matching “vaccine development”
University of Rochester HIV/AIDS Clinical Trials Unit
$1,817,383Michael C Keefer · University Of Rochester · UM1 · FY2025 · AI
SOFT TISSUE SARCOMA PROGRAM PROJECT
$1,817,039Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Emory/Atlanta Center for AIDS Research
$1,816,749James W. Curran · Emory University · P30 · FY2010 · AI
Toward a Universal Influenza Virus Vaccine
$1,816,495Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2021 · AI
Bacteria and Host in TB Transmission
$1,816,206David Alland · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease
$1,815,951Mark T Dransfield · University Of Alabama At Birmingham · UH3 · FY2019 · TR
T CELL MEMORY TO PATHOGENS: GENERATION AND FUNCTION
$1,815,757Trudeau Institute, Inc. · P01 · FY2004 · AI
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients
$1,815,533Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2023 · AI
Role of the microbiota in immunity
$1,815,394Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Case Clinical Trials Unit
$1,815,053Benigno Rodriguez · Case Western Reserve University · UM1 · FY2018 · AI
NCI-Frederick Support and Technical Services
$1,814,908Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2014 · CA
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
$1,814,563Powel H Brown · University Of Tx Md Anderson Can Ctr · UG1 · FY2020 · CA
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
$1,814,428Matthew Eugene Pipkin · Scripps Florida · P01 · FY2021 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase Function
$1,814,180Pamela Schwartzberg · National Human Genome Research Institute · Z01 · FY2008 · HG
T Cell Memory to Pathogens: Generation and Function
$1,813,970Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2013 · AI
Colorado Head and Neck Cancer SPORE
$1,813,896Antonio Jimeno · University Of Colorado Denver · P50 · FY2024 · CA
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,813,428Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
$1,813,195Lorenzo Leggio · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Metapopulation Models and Control of Tuberculosis in African Buffalo
$1,812,146Wayne M Getz · University Of California-Berkeley · · FY2000 · BIO
COALITION FOR HIV VACCINE DEVELOPMENT
$1,811,587University Of Maryland Baltimore · U01 · FY2000 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$1,811,310Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Sample Collection and General Screening Protocols
$1,811,137Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
ZIKA VIRUS VACCINE TARGET DEVELOPMENT IN A MOUSE MODEL OF DISEASE
$1,811,037The Regents Of The University Of Colorado · · FY2017 · Department of the Army
Pathogenesis of Tick-Borne Flavivirus Infections
$1,810,666Marshall Bloom · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Cellular & Molecular Defects in Human B Cell Development
$1,809,366Charlotte Cunningham-Rundles · Icahn School Of Medicine At Mount Sinai · P01 · FY2013 · AI